TABLE 1.
Univariate and multivariate Cox regression analysis of SQLC.
Variables | Univariate analysis |
Multivariate analysis |
||
Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | |
Age (≤65 vs. >65) | 1.237 (0.908–1.686) | 0.178 | 1.285 (0.932–1.771) | 0.126 |
Gender (male vs. female) | 0.899 (0.637–1.268) | 0.544 | 0.800(0.562–1.138) | 0.215 |
Tumor stage | ||||
T1 | 1 | 1 | ||
T2 | 1.274 (0.859–1.890) | 0.229 | 1.302(0.862–1.969) | 0.210 |
T3 | 1.972 (1.204–3.231) | 0.007 | 2.245 (1.093–4.612) | 0.028 |
T4 | 2.491 (1.308–4.744) | 0.005 | 3.250 (1.288–8.196) | 0.013 |
N stage | ||||
N0 | 1 | 1 | ||
N1 | 1.205 (0.862–1.684) | 0.275 | 1.361 (0.780–2.374) | 0.278 |
N2 | 1.405 (0.862–2.292) | 0.173 | 1.521 (0.622–3.722) | 0.358 |
N3 | 2.987 (0.733–12.174) | 0.127 | 5.574 (1.005–30.929) | 0.049 |
Clinical stage | ||||
I | 1 | 1 | ||
II | 1.235 (0.871–1.750) | 0.236 | 0.918 (0.507–1.661) | 0.777 |
III | 1.784 (1.229–2.591) | 0.002 | 0.874 (0.330–2.315) | 0.787 |
IV | 2.251 (0.707–7.166) | 0.170 | 1.579 (0.419–5.959) | 0.500 |
8-IRG risk score (low vs high) | 1.600 (1.168–2.193) | 0.003 | 1.937 (1.382–2.715) | <0.001 |
HR, hazard ratio; CI, confidence interval; IRG, immune-related genes.